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inhalation associated with structural fires, wildfires, or explosions
leads to lung injury, for which innovative and clinically relevant
animal models are needed to develop effective therapeutics. We have
previously reported that damage-associated molecular patterns
(DAMPs) and anti-inflammatory cytokines correlate with infectious
complications in patients diagnosed with inhalational injury. In this
study, we describe a novel and translational murine model of acute
inhalational injury characterized by an accumulation of protein and
neutrophils in the bronchoalveolar space, as well as histological
evidence of tissue damage. Mice were anesthetized, and a cannula was
placed in the trachea and exposed to smoldering plywood smoke three
times for 2-min intervals in a smoke chamber. Here we demonstrate
that this model recapitulates clinically relevant phenotypes, including
early release of double-stranded DNA (dsDNA), IL-10, monocyte
chemoattractant protein (MCP)-1, and CXCL1 along with neutro-
philia early after injury, accompanied by subsequent susceptibility to
opportunistic infection with Pseudomonas aeruginosa. Further inves-
tigation of the model, and in turn a reanalysis of patient samples,
revealed a late release of the DAMP hyaluronic acid (HA) from the
lung. Using nitric oxide synthase-deficient mice, we found that Nos2
was required for increases in IL-10, MCP-1, and HA following injury
but not release of dsDNA, CXCL1 expression, early neutrophilia, or
susceptibility to opportunistic infection. Depletion of CXCL1 attenu-
ated early neutrophil recruitment, leading to decreased histopathology
scores and improved bacterial clearance in this model of smoke
inhalation. Together, these data highlight the potential therapeutic
benefit of attenuating neutrophil recruitment in the first 24 h after
injury in patients.
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INTRODUCTION
Acute smoke inhalation injury presents a clinical challenge.
Acute smoke inhalation occurs during structural fires or wild-
fires, which are increasing in number and size across the
United States. According to statistics compiled by the Insur-
ance Information Institute, 61,920 wildfires burned in the
United States in 2016 compared with 58,225 in 2015. Over
10% of households are at extreme risk in Idaho, Colorado,
California, New Mexico, Texas, and Utah, placing millions of
households at extreme risk for smoke inhalation injury. Inha-
lational injuries result in severe and complex damage to the
lung and are associated with lengthy and expensive hospital-
izations, especially when they occur concomitantly with cuta-
neous burn injury (2). In cases where smoke inhalation is
accompanied by cutaneous burns, lacerations, or fractures,
inhalational injury is treated last, since it is dwarfed by the
immediacy of these other traumatic injuries (37).
The short- and long-term physiological imbalances that
result from acute smoke inhalation injury are not completely
understood, in large part because a systematic analysis of
patient outcomes is complicated by the confounding variables
(e.g., cutaneous burns) that normally accompany inhalation
injury. In addition, this patient population spans all ages,
ethnicities, and comorbidities. Moreover, the severity of the
inhalational injury depends on the smoke source, concentra-
tion, and duration of exposure. For example, synthetic materi-
als often burn faster and release more toxins than wood;
therefore, as synthetic materials become more prevalent in
construction, the types of lung injuries treated at trauma centers
become more diverse (37).
A leading cause of morbidity and mortality following inha-
lational injury is bacterial pneumonia, which is thought to be
the result of poor mucociliary clearance coupled with impaired
immunological surveillance (41). Some studies have examined
patient bronchoalveolar lavage fluid (BALF) to characterize
the inflammatory state, identify patients at risk for developing
pneumonia, and thus initiate antibacterial prophylaxis in high-
risk patients. Two damage-associated molecular patterns
(DAMPs), double-stranded DNA (dsDNA) and hyaluronic
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acid (HA), have been demonstrated to be elevated in patients
with inhalational injury, especially those who subsequently
develop bacterial pneumonia (29). In addition, our group has
previously shown that IL-10 was elevated in patients who
develop pulmonary or peripheral bacterial infections, and oth-
ers have observed elevated IL-10 in patients who do not
survive inhalational injury (10, 22). The prevailing opinion is
that trauma leads to release of DAMPs that lead to a suppres-
sion of inflammation and contribute to patients’ inability to
fight opportunistic bacterial infections; however, we have not
observed a direct correlation between the concentrations of
DAMPs and IL-10 in patients. We therefore sought to develop
a translational mouse model of inhalational injury to probe the
relationship between local DAMP release in response to inha-
lation injury and short- and long-term local immune function as
it relates to susceptibility to opportunistic infection.
Wood smoke inhalation elicits a clinically relevant injury
model. A reliable small animal model of disease is an invalu-
able resource for identification of mechanism(s) to inform the
development of and test the efficacy of therapeutic interven-
tions. Several studies have used small (e.g., mice, rats) and
large (e.g., sheep, pigs) animal models to address acute smoke
inhalation, primarily using cotton as a source of smoke (15, 25,
26, 30, 33, 39, 42). Neutrophil accumulation and activation are
associated with oxidative tissue damage in an ovine model of
cotton smoke inhalation and bacterial infection (26). Inhibiting
protein oxidation in a mouse model of cotton smoke inhalation
with burn injury resulted in elevated IL-10 and an improve-
ment in lung structure (15). Notwithstanding these insights,
there are still significant differences between the clinical ob-
servations in humans and the results of animal studies, under-
lying the need for preclinical models that more closely mimic
the clinical setting (15, 37). Despite differences in magnitude,
innate immune responses to stressors are largely similar in
humans and mice, including cytokine and chemokine produc-
tion and leukocyte activation (9). Thus, in this study, we
describe and use a novel murine model of acute exposure to
smoke from plywood, a common building material comprised
of wood and adhesives. This model uses a source of smoke that
is more representative of the type of injury observed within
burn centers, resulting in the recapitulation of many pheno-
types previously described in patients diagnosed with an inha-
lational injury and key traits of murine lung injury. We em-
ployed this model to address the hypothesis that immune
activation early after smoke inhalation injury leads to damage
to the tissue architecture and inflammation, which renders the
lung vulnerable to subsequent bacterial challenge. In addition,
we establish the utility of this model for testing interventions
that counteract the negative physiological consequences of
smoke inhalation. Specifically, we report that exposure to
wood smoke leads to accumulation of DAMPs (HA and
dsDNA), elevated levels of IL-10, monocyte chemoattractant
protein (MCP)-1, and CXCL1, and neutrophil accumulation in
BALF. Furthermore, mechanistic studies demonstrate that
Nos2 expression is necessary for injury-induced elevations in
IL-10, MCP-1, and HA but not for changes in CXCL1, neu-
trophil recruitment, or the susceptibility to bacterial challenge.
In contrast, CXCL1 neutralization results in an approximate
50% decrease in neutrophil recovery from the BALF following
injury and improved bacterial clearance. Thus, this study es-
tablishes the utility of this model in determining mechanisms
that drive this complex injury and highlights its suitability for
testing interventions that counteract the negative physiological
consequences of smoke inhalation.
MATERIALS AND METHODS
Mouse housing and care. Female (or male, where stated) C57BL/6
mice aged 8–10 wk were purchased from Taconic Farms and housed
in specific pathogen-free facilities. All protocols were approved by the
University of North Carolina (UNC) at Chapel Hill’s Institutional
Animal Care and Use Committee and were verified to follow guide-
lines from the National Institutes of Health concerning use of verte-
brate animals in research.
Smoke inhalation. Mice were anesthetized using tribromoethanol
(475 mg/kg; Sigma-Aldrich), and their dorsum was shaved
(NC0854145; Fisher) before injection of subcutaneous morphine
sulfate (3 mg/kg; Westward). Mice were then placed on an intubation
platform (Penn Century). The trachea was visualized with a laryngo-
scope, and a cannula (22 G  1 in.; Exel) was placed in the trachea.
Mice were kept in a supine position and placed in an animal induction
chamber (NC9296517; Stoelting). Plywood sectioned into strips
(2.5  8 cm, allowed to equilibrate in a 45% humidity and 65°F
temperature controlled room for 2 wk before the experiment, item no.
12206, model no. 776391100000; Lowe’s) was placed in a side-arm
flask on a heat block set to 500°C, causing the board to smolder and
produce smoke (outlined in Fig. 1A). Wood (~50 g) was used at the
start of experiments, with additional pieces added as needed. Air
pumped through the flask forced smoke in the induction chamber for
three exposures of 2 min with a 1-min break between exposures. Clear
walls of the induction chamber allowed visual assessment of smoke
density; air pressure was kept constant, and the chamber was vented
or kept sealed to maintain smoke density that resulted in visual
obstruction at 1–1.5 in. In a closed chamber under our prescribed
exposure conditions, we quickly reached the maximum value of
optical density attained by plywood smoke (295 for unfinished ply-
wood; see Ref. 18). For the first preliminary experiments we used a
photometer, and the smoke density exceeded the maximum specific
optical density and therefore the meter’s range (18), and that density
was the only density to produce significant particle accumulation in
the lungs. We used a filter placed in the circuit that allowed us to
weigh the deposited smoke particles, which we found to be consistent
between experiments. The time taken to reach the maximum specific
optical density was also consistent between experiments. Moreover,
visual inspection of catheters removed from mouse airways confirmed
deposition of soot on the end of the catheters (Fig. 1B) and upper
airways; soot was similarly observed in the trachea of mice euthanized
within 24 h of inhalational injury (Fig. 1C). The heat plate, flask, and
induction chamber were set up in a dedicated fume hood as outlined
in Fig. 1A. Mice were allowed to recover on a heating pad, were
resuscitated with an intraperitoneal injection of lactated Ringer’s
solution (1 ml/kg body wt; Baxter Healthcare), and were given
morphine in their drinking water ad libitum for the duration of the
experiment. Sham mice were treated identically except that air was
pumped in the induction chamber rather than smoke. Before tissue
collection, mice were euthanized with gaseous isofluorane.
Bacterial infection. Pseudomonas aeruginosa (strain PA01) was
grown in Luria-Bertani (LB) broth at 37°C with shaking to reach the
midlog phase growth. Bacterial pellets were washed and resuspended
with cold PBS with 1% Protease Peptone (PP-PBS) and diluted to
5  106 colony-forming units (CFU)/ml. Serial dilutions of inoculum
were plated on LB agar to confirm bacterial dosage. Inoculum (200
l) was administered to mice via tail vein injection; mock-infected
mice received 200 l PP-PBS. Bacterial burden in the airway at time
of harvest was determined by plating 100 l of BALF in duplicate on
LB agar. Bacterial burdens in liver and spleen were determined by
plating serial dilutions of organ homogenate in PP-PBS on LB agar
plates.
Bronchoalveolar lavage sample acquisition and processing. To
collect BALF, a catheter (22 G  1 in.; Exel) was inserted in the
trachea and connected to a syringe containing 1 ml 0.6 mM EDTA in
PBS; 0.6 ml was instilled in the lungs and then withdrawn three times
to obtain a primary wash. Typical recovery was 0.75 ml. Two
subsequent washes were combined to obtain a secondary wash, for
which typical recovery was 2 ml. Cell pellets from primary and
secondary washes were combined for analysis via flow cytometry or
pelleted and stored at 80°C for subsequent analysis by qPCR.
Cell-free supernatant from primary wash was analyzed by Bradford
assay and enzyme-linked immunosorbent assay for IL-10, hyaluronic
acid, CXCL1, CXCL2 (R&D), IL-12, and MCP-1 (eBioscience)
according to the manufacturer’s instructions. Cell-free DNA was
enriched from secondary BALF supernatant. Briefly, 500 l of BALF
supernatant were treated with 50 l of Proteinase K solution and 125
l of S&P Proteinase K Digestion Buffer (Zymo Research, Irvine,
CA). Following proteinase K addition, samples were incubated for 30
min at 55°C and then 2.7 volumes of S&P DNA binding buffer (Zymo
Research) were added to each sample. Samples were then mixed and
added to Zymo-Spin III-S columns for DNA isolation per the manu-
facturer’s protocol. Cell-free dsDNA (cfDNA) was eluted from the
column using 50 l of prewarmed DNA Elution Buffer (Zymo
Research). Total cfDNA per millilter of BALF input was determined
using the Qubit 3.0 fluorimeter (Life Technologies) and the Qubit
dsDNA high-sensitivity detection reagents (Life Technologies).
Lungs were removed from mice after lavage. Minced lung tissue
was digested in 4 ml PBS with 10% fetal bovine serum (PBS-FBS),
1,500 g/mouse collagenase (Worthington), and 0.1 g/mouse DNase
and shaken at 250 rpm at 37°C for 1 h. Samples were filtered through
a 100-m cell strainer. Red blood cells were removed with ACK
Lysis Buffer, and remaining cells were suspended in PBS-FBS before
flow cytometric analysis. Live cells from lung digest and BALF were
counted manually with a hemocytometer using 0.01% trypan blue cell
viability dye (Life Technologies).
Flow cytometry. Following incubation with Fc Block (eBiosci-
ences), cells were stained with labeled antibodies against CD45,
CD11b, CD11c, and Ly6G (eBiosciences; BD Biosciences). Cells
were fixed with 1% paraformaldehyde before analysis on a CyAn
(Beckmann-Coulter). Samples were analyzed with Summit 5.1 soft-
ware (Beckmann-Coulter). Following exclusion of CD45-CD11b-
CD11c cells, Neutrophils were defined as CD45CD11b
CD11cLy6G, and macrophages were defined as CD45
CD11cLy6G.
Isolation and analysis of gene expression by qRT-PCR. Total RNA
was isolated using the RNeasy Mini-RNA extraction kit (Qiagen) for
BALF cells and the RNeasy Mini-RNA Fibrous Tissue kit (Qiagen)
from mouse whole lungs. Reverse transcription reactions were per-
formed with the VILO Reverse Transcription master mix (Life Tech-
nologies) using 0.25 g of total RNA. Real-time qRT-PCR was
performed using the QuantStudio 6 (Life Technologies) machine and
TaqMan Gene Expression master mix (Thermo-Fischer). Each reac-
tion contained 1 TaqMan Gene Expression master mix, cDNA from
40 ng of RNA, and 1 of gene-specific primer/probe combinations
(catalog no. 4331182; Gapdh Primer ID Mm99999915_g1, TATA
box-binding protein Primer ID Mm01277042_m1, IL-10 Primer ID
Mm01288386_m1, NOS2 Primer ID Mm 010927.3, IL-12b Primer
ID Mm01288989_m1, matrix metalloproteinase (MMP)-8 Primer ID
Mm00439509_m1, MMP9 Primer ID Mm00442991_m1; Life Tech-
nologies) in a total volume of 20 l. PCR was performed in duplicate
by cycling at 50°C for 2 min and 95°C for 15 min followed by 40
cycles of denaturation at 95°C for 10 s and annealing and extension at
60°C for 30 s. Values were derived using the CT method compar-
ing sham mice with inhalation injury mice at each time point, and
mRNA levels were normalized to housekeeping genes (GAPDH and
TATA box-binding protein).
Isolation and analysis of cytokine and chemokine levels by multi-
plex analysis. BALF was collected as above, and we employed
multiplex analysis of 33 chemokines and cytokines (BCA-1/CXCL13,
CTACK/CCL27, ENA-78/CXCL5, Eotaxin/CCL11, Eotaxin-2/
CCL24, Fractalkine/CX3CL1, GM-CSF, I-309/CCL1, interferon-,
IL-1, IL-2, IL-4, IL-6, IL-10, IL-16, IP-10/CXCL10, I-TAC/










Fig. 1. Development of an animal model of
inhalation injury. Schematic of the laboratory
setup of the smoke inhalational model (A),
deposition of soot on the cannula used to
intubate the mice undergoing injury (B), and
smoke particles within lung lobes of injured
mice (C).
CCL12, MDC/CCL22, macrophage inflammatory protein (MIP)-1	/
CCL3, MIP-1/CCL4, MIP-2/CXCL2, MIP-3	/CCL20, regulated
upon activation normal T cell expressed and secreted/CCL5, MIP-3/
CCL19, SCYB16/CXCL16, stromal cell-derived factor-1	/CXCL12,
TARC/CCL17, TECK/CCL25, tumor necrosis factor-	) according to
the manufacturer’s instructions (Bio-Plex Pro Mouse Chemokine
Panel 33-Plex no. 12002231; Bio-Rad).
Histopathology. To prepare lung tissue for histology, lungs were
inflated with 4% paraformaldehyde in PBS to a constant pressure of
20 cmH2O. Inflated tissue was stored overnight in 4% paraformalde-
hyde and then rinsed with 70% ethanol. Left lobes were embedded in
paraffin, and 4-m sections of tissue containing large airway branches
were cut and stained with hematoxylin and eosin at the UNC Chapel
Hill Animal Histopathology Core Facility. Images of deidentified
specimens were taken at the UNC Microscopy Services Laboratory
using an Olympus BX61 light microscope. At least 10 nonoverlapping
images of distal lung tissue (excluding major blood vessels and large
airways) were taken per specimen using the UPlanFLN 40/0.75
objective. The UPlanFLN 20/0.50 objective was used to obtain
sequential images of a large airway. Images of the distal lung tissue
were scored on a scale of 0 (normal) to 2 (maximal) for neutrophil
infiltration, proteinaceous debris, and congestion in microvasculature.
Images of large airway sections were scored for the same traits in
addition to cytoplasmic vacuolization and soughing of airway epithe-
lial cells. For each characteristic, the average score for 10–15 images/
specimen was calculated, and the sum of those values was obtained to
produce a cumulative tissue damage score (Table 1). Reported scores
were obtained by a single blinded individual, and findings were
confirmed by a second blinded individual.
Patient Samples. Patient BALF was obtained and analyzed as
previously described (22). Briefly, subjects were admitted to the North
Carolina Jaycee Burn Center at UNC who carried diagnoses of
inhalation injury and were intubated with mechanical ventilation.
Subjects were enrolled over a 2-yr period and followed until discharge
or death. Serial bronchial washings from clinically indicated broncho-
scopies were collected and analyzed for markers of tissue injury and
inflammation. This study was approved by the UNC Biomedical
Institutional Review Board (study no. 10–0959). In this analysis we
excluded subjects for whom HA was only measured at days 0 and 1.
Statistical analysis. GraphPad Prism version 5.0 for Windows was
used to analyze data by Student’s t-test, one-way analysis of variance
(ANOVA) with Tukey’s posttest, or two-way ANOVA with Bonfer-
roni posttest, as appropriate. In cases where data are represented in
relation to sham average, one-sample t-test was used to compare
values and means with a hypothetical value of 1. Data are presented
as means 
 SE. Statistical significance is indicated at the 0.05, 0.005,
and 0.001 levels.
RESULTS
Inflammatory cells migrate to the lung after smoke
inhalation. BALF from sham mice and mice who were ex-
posed to plywood smoke was used to enumerate live cells and
analyze the total protein content in BALF supernatants. Quan-
tification of live cells in the BALF revealed increased cell
numbers at 24, 48, 72, and 96 h following smoke inhalation
compared with sham-treated controls (Fig. 2A). There was also
an increase in the total protein concentration in BALF from
smoke-exposed mice at 24 and 96 h postinjury (Fig. 2B). Using
flow cytometry to characterize cells isolated from the BALF,
we observed an increase in the total number of neutrophils
following smoke inhalation compared with sham-treated mice
(Fig. 2C). In contrast, macrophage numbers in the BALF were
not significantly altered by smoke inhalation (Fig. 2D). Lung
digests revealed that smoke inhalation did not cause a signif-
icant change in the number of either neutrophils or macro-
phages in interstitial lung tissue at 24, 48, or 96 h (Fig. 2, E and
F). Although there are sex differences in patient and murine
responses to burn (36) that lead to a suppression of inflamma-
tion, we observed a similar influx of neutrophils and macro-
phages to the airway of male mice compared with females (Fig.
2, C and D). We therefore used female mice for the rest of the
study to be consistent with previous studies using our murine
cutaneous burn models (5–7, 14, 28, 34).
To characterize polarization of immune cells in the BALF,
expression of Nos2 mRNA was quantified by qRT-PCR. Nos2
mRNA was significantly increased in immune cells isolated
from smoke-treated mice relative to sham-treated mice at 24
and 48 h postinjury (Fig. 2G). RNA expression of MMP8 (also
known as neutrophil collagenase) and MMP9 (gelatinase B)
was also quantified in cells extracted from BALF by qRT-PCR.
We observed an increase in the expression of MMP9 but not
MMP8 at both 24 and 96 h following smoke inhalation com-
pared with sham-treated mice (Fig. 2H). By contrast, smoke
inhalation did not cause a change in either MMP8 or MMP9 in
interstitial lung tissue (data not shown).
To characterize damage to lung tissue following smoke
inhalation, sections of fixed lung tissue were analyzed for five
indicators of histopathology, and a tissue damage score was
calculated for both distal lung tissue and large airway epithe-
lium (Table 1). Quantitative assessment of lung damage by
blinded observers indicated significant damage to the large
airways at 24 h and to distal lung tissue at 96 h postsmoke
inhalation (Fig. 3, A and B). Proteinaceous and cellular con-
gestive material was seen within the alveolar spaces of smoke-
treated mice compared with sham-treated mice, consistent with
the greater concentration of protein observed in the BALF (Fig.
3, D and E). Analysis of specimens taken 96 h following
smoke inhalation indicated greater congestion of the pulmo-
nary microvasculature and mild thickening of the alveolar
walls due to both congestion and edema in distal lung tissue
(Fig. 2E). We observed cytoplasmic vacuolization and
sloughing in epithelial cells of the large airways of smoke
mice compared with sham within 24 h of smoke inhalation
(Fig. 3, F and G) as well as debris and occasional aggregates
of macrophages at 96 h (Fig. 3H).
IL-10 expression precedes HA DAMP release following
smoke inhalation. We have previously demonstrated that ele-
vated IL-10, a skewed IL-10-to-IL-12 ratio, and elevations in
Table 1. Histopathological scores of DLT and LA at 24 and
96 h after smoke inhalation or sham procedure
Sham 24 h 96 h
DLT
Neutrophils 0.16 (0.10) 0.42 (0.22) 0.57 (0.29)
Proteinaceous debris 0.42 (0.12) 0.64 (0.40) 0.36 (0.04)
Congestion 0.06 (0.05) 0.21 (0.23) 0.45 (0.29)
Cumulative DLT score 0.64 (0.14) 1.27 (0.76) 1.38 (0.37)*
LA
Neutrophils 0.00 (0.00) 0.00 (0.00) 0.04 (0.08)
Sloughing 0.07 (0.06) 0.01 (0.03) 0.04 (0.05)
Cytoplasmic blebbing 0.45 (0.22) 0.39 (0.22) 0.25 (0.17)
Cytoplasmic vacuolization 0.05 (0.09) 0.84 (0.16)** 0.09 (0.15)
Congestion 0.06 (0.07) 0.12 (0.20) 0.13 (0.11)
Cumulative LA score 0.63 (0.16) 1.37 (0.58)* 0.56 (0.43)
Values are means (SD); n  4 mice/treatment group, pooled from 2 separate
experiments. DLT, distal lung tissue; LA, large airway. *P  0.05 and **P 
0.005.
the DAMPS dsDNA and HA are reliable predictors of patient
outcomes following inhalation injury although the mechanistic
relationship between these biomarkers and subsequent infec-
tion has not yet been established (22, 29). In mice exposed to
plywood smoke, IL-10 was significantly elevated in BALF at
24 h compared with uninjured mice; however, the increase was
transient and was not significant at subsequent time points (Fig.
4A). These data are supported by qRT-PCR, which illustrated
an increase in IL-10 mRNA in cells recovered from the BALF
of injured animals normalized to sham average at 24 h (Fig.
4B), normalizing relative to sham-treated mice between 48
and 96 h. No significant changes in IL-12 protein or mRNA
in BALF were observed at any time (data not shown). In
lung tissue, no statistically significant changes in IL-10 gene
expression were observed at either 24 or 96 h (Fig. 4C).
IL-12 gene expression was significantly downregulated in
lung tissue at 96 h following smoke inhalation compared
with controls (Fig. 4C).
To establish the presence of DAMPs in the animal model,
which have been used to predict patient outcome, HA and
cfDNA were measured in BALF following smoke inhalation or
sham procedure. The sham procedure did not change levels of
HA or dsDNA at any time point evaluated (Fig. 4, D and E).
By contrast, cfDNA was elevated in injured mice compared
with shams at 12–24 h before returning to baseline by 48 h
(Fig. 4D). In addition, we observed that concentrations of HA
Fig. 2. Neutrophilic inflammation following
acute wood smoke inhalation. A: total live
cells were enumerated in bronchoalveolar
lavage fluid (BALF) at indicated time points
following smoke or sham procedure. B: pro-
tein concentration in BALF cell-free super-
natant was measured by Bradford assay.
C–F: neutrophils and macrophages were
quantified by flow cytometry and normalized
to live cell counts in BALF (C and D) and
whole lung (E and F) following injury. G
and H: Nos2 (G) and matrix metalloprotei-
nase (MMP)-8 and MMP9 (H) mRNA ex-
pression was measured in BALF cells at
indicated time points after smoke procedure
and were normalized to sham average at each
time point. Two-way ANOVA with Tukey’s
posttest (A–F) or 1-sample t-tests vs. sample
value  1 (G and H) were used to determine
statistical significance at all time points. *P 
0.05, **P  0.005, and ***P  0.001, repre-
sentative of 3 repeated experiments. No. of
mice as follows: n  5 sham and n  6
inhalation injury (A–F), 5 sham and 6 inhala-
tion injury (G), and 5 sham and 7 inhalation
injury (H) mice.
increased over time following smoke inhalation, reaching a
peak at 72–96 h (Fig. 4E). We analyzed our patient data and
found that this late peak in BALF HA expression in the mouse
model of inhalational injury was mirrored in patients diagnosed
with inhalational injury (Fig. 4F).
Pulmonary infection develops after systemic inoculation in
mice following smoke inhalation. Patients diagnosed with in-
halational injury frequently develop pneumonia following col-
onization by opportunistic bacteria, most commonly P. aerugi-
nosa (6). We therefore propose that any clinically relevant
animal model of smoke inhalation injury should render mice
susceptible to bacterial challenge that does not cause infection
in uninjured mice. Mice were exposed to an intravenous
inoculation with P. aeruginosa (strain PA01) 48 h following
smoke exposure or sham treatment. The recovery of bacteria
from BALF was quantified at 24, 48, and 96 h following
infection (Fig. 5A). In sham mice we detected nominal, if any,
bacteria in the BALF; after smoke inhalation, we consistently
observed substantial CFUs from BALF significant amounts of
bacteria at 24, 48, and 96 h after inoculation. Bacterial recov-
ery from the systemic compartments of the liver and spleen
tissue was sporadic and unaltered by injury status (data not
shown). Infection further exacerbated pulmonary damage in
the smoke-injured mice, demonstrated by increased concentra-
tions of protein and HA in the BALF compared with sham
mice (Fig. 5, B and C). Taken together, these data demonstrate
using bacterial infection as a clinically relevant readout; these
data demonstrate that we have developed a model of
woodsmoke inhalation that closely recapitulates the immuno-
suppressive sequalae seen in humans.
Differential regulation of injury phenotypes by Nos2. Nos2
activity is known to modulate neutrophil recruitment and
activation as well as cytokine and chemokine production (3).
Nos2 expression has been demonstrated to be increased fol-
lowing smoke inhalation (33, 39). We therefore designed a
series of experiments to determine the impact of Nos2 expres-
sion on inflammation following acute smoke inhalation. Nitric
oxide synthase-deficient (Nos2/) mice were either subjected
to wood smoke inhalation injury or sham procedure, after
which BALF and susceptibility to infection were evaluated as
previously described. Neither BALF protein nor neutrophil
accumulation after smoke inhalation was different in Nos2/
mice compared with wild-type controls at either 24 (data not
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Sham 24h  96h
Fig. 3. Histological evidence of lung injury
following acute smoke exposure. Sections of
lung tissue were analyzed by histology and
scored by blinded individuals. Tissue injury
score in sections of distal lung tissue sections
(A) and large airway sections (B) in pooled
sham mice and smoke-treated mice at 2 time
points. P value represents Tukey’s posttest
following a 1-way ANOVA. Representative
images of distal lung tissue from sham (C),
24-h post-smoke-treated (D), and 96 h post-
smoke-treated (E) mice are shown. Represen-
tative images of large airway from sham (F),
24 post-smoke-treated (G), and 96-h post-
smoke-treated (H) mice are shown. Scale bars
correspond to 50 m. *P  0.05 and ***P 
0.001, representative of 3 experiments; n  5
sham and 6 inhalation injury mice (A and B).
MCP-1 were elevated in BALF 24 h following smoke inhala-
tion in wild-type mice, a similar increase was absent in
Nos2/ mice (Fig. 6, C and D). In addition, the inhalation
injury-induced increase in BALF HA concentration at 96 h was
also attenuated in Nos2/ mice, and we did not observe a
significant increase in BALF dsDNA concentrations at 24 h
after inhalational injury in Nos2/ mice (Fig. 6, E and F).
Finally, a Nos2-dependent difference in bacterial clearance
Fig. 4. IL-10 precedes damage-associated
molecular pattern (DAMP) release following
smoke inhalation. A: IL-10 concentration in
primary BALF cell-free supernatant follow-
ing inhalational injury, normalized to sham
average concentrations at each time point. B:
IL-10 mRNA expression in BALF cells nor-
malized to sham average at indicated time
points after injury. C: IL-10 and IL-12
mRNA expression in lung tissue, normalized
to sham average expression at each time. P
values reflect1-sample t-tests vs. sample
value  1. D and E: cell-free double-
stranded DNA (cfDNA) concentration in sec-
ondary BALF supernatant (D) and hyaluronic
acid concentration in primary BALF super-
natant (E) were analyzed by 2-way ANOVA
with Tukey’s posttest to determine signifi-
cance between groups at each time point. F:
hyaluronic acid concentration in BALF sam-
ples from patients diagnosed with inhala-
tional injury, and P value represents 1-way
ANOVA with posttest vs. day 0 (0d) concen-
trations. *P  0.05 and ***P  0.001, rep-
resentative of 3 experiments. No. of mice as
follows: n  5 sham and 6 inhalation injury
(A, D, and E), 5 sham and 8 inhalation injury
(B), 5 sham and 5 inhalation injury (C), and
5 sham and 10 (0d), 15 (1d), 24 (2d), and 12
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Fig. 5. Pulmonary infection develops subsequent to systemic inoculation in mice following smoke inhalation. A: colony-forming units (CFU) of recovery from 
BALF of mice infected with 1   106 CFU PA01 at 48 h after sham or smoke procedure and harvested at various time points following infection. Broken line 
represents the limit of detection. B and C: protein concentration (B) and hyaluronic acid (C) concentration in BALF cell-free supernatant of mice infected with 
1   106 CFU PA01 at 48 h after sham or smoke procedure and harvested 48 h after infection; data are pooled from 3 independent experiments. *P 
 0.05. No. of mice as follows: n 
 6 sham and 9 (24 h), 10 (48 h), and 7 (96 h) inhalation injury (A) and 5 sham and 5 inhalation injury (B and C) mice.
following an intravenous challenge of P. aeruginosa was not
observed (data not shown).
CXCL1 drives lung neutrophil accumulation and infection
clearance in the lung following smoke exposure. To delineate
potential chemotactic signals responsible for neutrophil recruit-
ment to the airway following smoke inhalation, we measured the
neutrophil chemoattractants CXCL1 (also known as KC) and
CXCL2 (also known as Gro2 and Mip2) in BALF. At 24 h
postinjury we observed an increase in CXCL1 in BALF; however,
CXCL1 concentrations returned to baseline at all subsequent time
points (Fig. 7A). We did not detect CXCL2 in injured mice at any
time following injury (data not shown).
To determine whether CXCL1 was responsible for neutro-
phil recruitment to the airway following inhalational injury, a
CXCL1-neutralizing antibody (or isotype control) was admin-
istered intravenously at 0.5 and 24 h after smoke exposure.
Treatment with anti-CXCL1 resulted in a decrease in total
BALF neutrophil numbers at 48 (8.9-fold, P  0.03) and 72
(3.3-fold, P  0.01) h compared with smoke-exposed mice
treated with an isotype control (Fig. 7B). To determine whether
complete inhibition of neutrophil trafficking could be achieved
with higher antibody concentration, a series of increased con-
centrations of neutralizing antibody was used. Increased con-
centrations of neutralizing antibody did not further decrease
neutrophil numbers (data not shown), which suggests that
additional chemotactic signals contribute to neutrophil recruit-
ment, or can partially compensate for CXCL1.
To test whether attenuated neutrophil recruitment following
tissue injury impacted subsequent sensitivity to bacterial lung
infection, we intravenously infected anti-CXCL1 and isotype-
treated mice 48 h following inhalation injury with 1  106
CFU PA01 (experimental schematic in Fig. 7C). Pulmonary
bacterial burden was quantified 2 days after infection by CFU
analysis of BAL (Fig. 7D). Significantly less bacteria were
recovered from the airway of mice treated with anti-CXCL1
compared with those treated with isotype control (Fig. 7D).
Recruitment of neutrophils to the airway (Fig. 7E), protein
accumulation within the BALF (Fig. 7F), and HA accumula-
tion (Fig. 7G; modest yet significant decrease of ~10%, which
is unlikely to have biological significance) were unaltered by
administration of anti-CXCL1.
CXCL1 drives lung damage, inflammatory cytokine, and
chemokine following smoke exposure. Anti-CXCL1 antibody
reduced accumulation of neutrophils after smoke exposure
(Fig. 7B) yet did not impact subsequent neutrophil recruitment
following bacterial infection (Fig. 7E) and promoted increased
clearance of bacterial burden (Fig. 7D). Therefore, to examine
the possible mechanism(s) of the increased bacterial clearance,
we quantified the histopathology at 24 h after inhalation injury




























































































Fig. 6. Nos2 deficiency reverses IL-10,
monocyte chemoattractant protein (MCP)-1,
and hyaluronic acid (HA) after smoke inha-
lation. A: protein concentration in BALF at
96 h following sham or injury procedure. B:
neutrophils quantified by flow cytometry and
normalized to live cell counts in BALF at 96
h following injury. C and D: IL-10 (C) and
MCP-1 (D) concentration in BALF at 24 h. E:
HA concentration in BALF at 96 h. F:
cfDNA concentration in BALF at 24 h. Data
are pooled from 3 independent experiments.
Data were analyzed by 2-way ANOVA with
Tukey’s posttest. *P  0.05, **P  0.005,
and ***P  0.001. No. of mice as follows:
n  5 sham and 6 inhalation injury mice.
antibody or isotype control. We observed a significant decrease
in tissue damage scores in distal airway specimens from mice
treated with neutralizing antibody (Fig. 8A). This decrease was
primarily attributable to a decrease in cellularity and debris
congestion scores (0.93 
 0.11 vs. 0.27 
 0.28; P  0.05); we
did not observe any difference in protein levels released in the
BAL (Fig. 8B).
We also characterized the effect of anti-CXCL1 treatment on
the expression of an array of inflammatory cytokines and
chemokines in the BALF early after injury (Fig. 8, C–E). We
found that a subset of cytokines (IL-6, IL-1, and IL-16; Fig.
8C) was significantly increased after injury compared with
sham but significantly decreased at 24 h postinhalation injury
by anti-CXCL1 treatment compared with injured animals
treated with isotype-antibody. Reduction of these proinflam-
matory mediators may reflect reduction in neutrophils numbers
and associated lung damage. In contrast, CXCL5 (ENA78) was
significantly decreased by inhalation injury compared with
sham but not significantly impacted by anti-CXCL1 antibody
(Fig. 8D). A further subset of mediators (CCL25 and CXCL13;
Fig. 8E) was significantly elevated 48–72 h after injury in
anti-CXCL1-treated mice compared with isotype-treated ani-
mals. We hypothesize that these mediators are responsible for
increased chemotaxis that aids bacterial clearance during in-
fection.
DISCUSSION
Acute smoke inhalation and injury present a significant
clinical challenge for inhabitants of regions at risk for wild-
fires, survivors of structural fires, first responders, and mem-
bers of the armed forces. Inhalational injury is among a
spectrum of stimuli that can precipitate acute lung injury (ALI)
and acute respiratory distress syndrome (ARDS). Despite sig-
nificant research into targeted therapies for ALI/ARDS, an
effective pharmaceutical intervention does not currently exist
(21). The initiation and outcome of inhalational injury and ALI
are idiosyncratic, brought on by a multitude of stimuli, and
result in outcomes impacted by a host of comorbidities, includ-
ing inflammatory disorders and smoker status (21, 27, 31, 38).
It is therefore critical that research into inhalational injury and
ALI accounts for these complexities. Thus, preclinical animal
models and studies should be designed to replicate, as faith-
fully as possible, the etiology of human disease.
Here we report the development and utilization of a murine
model of acute exposure to smoke derived from plywood, a
common building material. This model recapitulates many of
the histopathological and immune phenotypes previously re-
ported to predict outcomes in patients, including a predomi-
nance of neutrophils in the airway, expression of IL-10, and
elevated DAMPs such as dsDNA and HA in the BALF fol-
Fig. 7. CXCL1 drives lung neutrophilia and
bacterial clearance following smoke expo-
sure. A: CXCL1 concentration in BALF at
24–96 h. B: mice were treated with anti-
CXCL1 or isotype control at 0 and 24 h
following injury. Neutrophils were quanti-
fied by flow cytometry and normalized to
live cell counts in BALF at 24 and 48 h
following injury. C: experimental design.
Mice were treated with anti-CXCL1 or iso-
type control antibody via tail vein injection
at 0 and 24 h following smoke exposure. At
48 h mice were inoculated with PA01 or
vehicle control via tail vein injection. Sam-
ples were collected at 48 h following infec-
tion, 96 h following injury. D: CFU recovery
from BALF of smoke-treated mice treated
with anti-CXCL1 or isotype control before
infection with PA01. E and F: neutrophils
from BALF quantified by flow cytometry (E)
and protein concentration in BALF of in-
fected mice treated with anti-CXCL1 or iso-
type control (F). G: HA concentration in
BALF following smoke and infection in
mice treated with anti-CXCL1 or isotype
control. Data were analyzed by 2-way
ANOVA with Tukey’s posttest. *P  0.05,
***P  0.001 representative of 3 experi-
ments. No. of mice as follows: n  5 isotype
and 6 anti-CXCL1 (A and B), 12 isotype and
9 anti-CXCL1 (D), and 5 isotype and 6
anti-CXCL1 (E–G) mice.
lowing injury (12, 22, 29). Experiments using hickory wood
chips (untreated/seasoned) resulted in similar changes in pro-
tein concentration and cell numbers. Further studies will ad-
dress the extent to which inflammation and tissue damage
differ depending on the source of smoke. Based on studies
using clinical samples, prevailing wisdom is that tissue damage
following inhalation injury leads to DAMP release, and sub-
sequent detection of DAMPs through scavenger receptors and
other pattern recognition receptors triggers an anti-inflamma-
tory signaling cascade to limit further damage resulting from
immunopathology. It is plausible that this evolutionary re-
sponse may be intended to minimize inflammation that would
compromise gas exchange across the alveolar-capillary barrier.
These informative clinical studies are limited because of the
challenges inherent in clinical research regarding the timing
and frequency of sample acquisition, which is especially
unique to this patient population. Data from the model pre-
sented here echo this published clinical data, suggesting that
anti-inflammatory cytokine production occurs rapidly in the
lung following injury. Clinical studies have also reported that
Fig. 8. Early inhibition of neutrophil migra-
tion protects against injury and induces spe-
cific chemokine and cytokine alterations.
Mice were treated with anti-CXCL1 or iso-
type control antibody via tail vein injection
at 0 and 24 h following smoke exposure.
BALF samples were collected at 24, 48, and
72 h following injury. A: representative tis-
sue injury scores from distal airway sec-
tions. B: protein concentration in BALF
cell-free supernatant was measured by
Bradford assay. C–E: multiplex analysis
was performed on BALF samples from
sham and injured animals with isotype or
anti-CXCL1 antibody. Data were analyzed
by 2-way ANOVA with Tukey’s posttest.
*P  0.05, representative of 3 experi-
ments. No. of mice as follows: n  5
isotype and 6 anti-CXCL1 mice (A–E).
macrophage numbers in the airway do not change between the
acute phase of ARDS and resolution; however, neutrophil
numbers are subject to change based on disease state (12). We
observed a similar phenotype in our model of acute exposure to
plywood smoke. Specifically, we demonstrated that macro-
phage numbers in BALF are unaltered by the injury, whereas
the number of neutrophils increases following smoke inhala-
tion (Fig. 1, C–F). The model also suggests a more delayed
mechanism of tissue damage typified by delayed HA release
(Fig. 4, E and F), which will be the focus of later investigation.
Therefore, this model can and will be used to further clarify the
dynamic relationship between DAMPs release and induction of
anti-inflammatory processes within the injured lung.
Because pneumonia poses a significant comorbidity and
challenge to patient recovery, any faithful animal model must
recapitulate susceptibility to opportunistic infection. In our
model of smoke inhalation, mice exposed to smoke from
plywood are susceptible to pulmonary infection following a
systemic bacterial challenge. Isolated smoke inhalation (as
opposed to burns) likely predisposes patients to more tracheo-
bronchial colonization with pathogen from an airborne route of
exposure, as opposed to bacteremia-induced lung injury. Al-
though our infection is restricted to the airway and is not
detectable in the liver or the spleen, one bias of the model
presented here is the route of infection leading to pulmonary
bacterial colonization. While we have used a direct intratra-
cheal aerosol route in previous studies (14, 32, 34), intratra-
cheal infections cause inflammation in both injured and unin-
jured mice. In this study, we aimed to use an infectious
challenge that would remain “subclinical” in uninjured mice;
thus, we avoided direct intratracheal inoculation. In addition,
even in the absence of cutaneous burn injury, patients with
inhalational injuries require intravenous fluids, and catheter-
related bloodstream infections are a significant cause of mor-
bidity and mortality in burn units where bloodstream infections
are thought to be a major source of the bacteria that colonize
and establish active infections in other organs, including the
lungs. Together these findings increase the translatability of
this infection model.
Importantly, because of the challenges inherent in clinical
research regarding the timing and frequency of sample acqui-
sition, this model clarifies the dynamic relationship between
DAMPs and anti-inflammatory cytokines in the injured lung.
Prevailing wisdom is that tissue damage leads to DAMP
release, and detection of DAMPs through scavenger receptors
and other pattern recognition receptors triggers an anti-inflam-
matory signaling cascade to limit further damage resulting
from immunopathology. Data from this model echo published
clinical data suggesting that anti-inflammatory cytokine pro-
duction occurs rapidly in the lung following injury; this evo-
lutionary response may be intended to minimize inflammation
that would compromise gas exchange across the alveolar-
capillary barrier. The model also suggests a more delayed
mechanism of tissue damage typified by delayed HA release,
which will be the focus of later investigation.
We used this novel and clinically applicable model of
inhalation injury to evaluate mechanisms that lead to the
increased susceptibility of opportunistic infections. Specifi-
cally, we probed the contributions of Nos2 and IL-8 (CXCL1/
KC). Others have reported that, in mice, cotton smoke inhala-
tion with and without burn injury led to an increase in Nos2
expression and activity in the airway (33) and that Nos2 is
expressed in macrophages and airway epithelial cells following
sepsis (8). In the current study we observed that, in the absence
of Nos2, many relevant injury phenotypes are absent or sig-
nificantly attenuated. Notably, Nos2 deficiency prevents
smoke-induced elevation of IL-10 and MCP-1 at 24 h, as well
as the release of HA but not cfDNA. These changes did not,
however, impact neutrophil recruitment or damage to the
alveolar-capillary barrier. Moreover, in support of other studies
that have demonstrated that Nos2 expression and activity is
dispensable for clearance of P. aeruginosa infection, we do not
observe any change in bacterial clearance in injured mice
deficient for Nos2 (4). It is worth noting that, in clinical
studies, we have reported that BALF levels of both IL-10 and
dsDNA correlate with the onset or susceptibility of infection
(22, 29). This contrasts with our data that indicate that dsDNA
can be elevated without a concomitant increase in IL-10 and
that these changes do not alter the outcomes following bacterial
challenge.
Significant clinical data suggest that expression of the potent
neutrophil chemoattractant IL-8 is elevated following trauma
and that its activity is a key determinant of clinical outcomes
(10, 40). For instance, a spike in IL-8 is observed in patient
serum following burn injury in the absence of sepsis (40), and,
in a study of inhalational injury, IL-8 was elevated in survivors
compared with those who succumbed to the injury (10). Con-
versely, in an animal model, inhibition of the murine IL-8
homolog CXCL1 (also known as KC) following burn resulted
in a decrease of several markers of lung injury (43). Here we
demonstrate that intravenous administration of a neutralizing
antibody against CXCL1 attenuates but does not abolish neu-
trophil recruitment to the airway following inhalation injury.
This phenotype corresponded with decreased tissue histo-
pathology (Fig. 8B) and did render the mice less susceptible
to infection (Fig. 7D). These data imply that neutrophils
accumulate under the direction of CXCL1 (Fig. 7B) after
woodsmoke and preinjure the lung, making bacterial clear-
ance less efficient (Fig. 7D). If CXCL1 is blocked, there is
less accumulation of neutrophils and less damage associated
with reduced proinflammatory response; however, other
chemotactic signals can compensate, resulting in neutrophil
recruitment to the lungs (and in equal measure to uninjured
mice) after bacterial infection with enhanced bacterial clear-
ance (Fig. 7E). Neutrophils are necessary and sufficient for
clearance of P. aeruginosa (24).
Altogether, we propose that, by attenuating, but not deleting,
neutrophil numbers by CXCL1 blockade, we can prevent the
early damage caused by neutrophils and, we hypothesize,
bolster bacterial clearance by enhancing other mechanisms of
immune chemotaxis. Indeed, we uncovered subsets of soluble
mediators that were significantly and differentially altered by
CXCL1 blockade after injury. One subset, represented by IL-6,
IL-1, and IL-16, was significantly decreased early (24 h) after
inhalation injury. These mediators have been associated with
proinflammatory shock, and their reduction may reflect reduc-
tion in neutrophils numbers and associated lung damage. IL-6
and IL-1 have been well studied in the context of burn injury,
with increased levels in serum and BALF correlating well with
poor clinical outcomes because of opportunistic infection (1,
11, 13, 16, 17, 19, 20). IL-16 is a cytokine released by a variety
of cells (including epithelial cells) that acts as a chemoattrac-
tant for CD4 immune cells such as T-helper cells, monocytes,
macrophages, and dendritic cells. Pulmonary epithelial-derived
CXCL5 has been shown to be critical for neutrophil-mediated
destructive inflammation in pulmonary infections (35). Reduc-
tion of these mediators after anti-CXCL1 treatment may be
responsible for the decreased recruitment of neutrophils and
associated lung damage after injury. In contrast, CCL25
(TECK), chemotactic for macrophages, and dendritic cells and
CXCL13, chemotactic for B cells during lung infections (23),
were significantly elevated 48–72 h after injury in anti-
CXCL1-treated mice compared with isotype-treated controls.
We hypothesize that these mediators are responsible for in-
creased (or restoration of) chemotaxis upon secondary bacterial
challenge, which aids in bacterial clearance of infection. This
may be by virtue of more surviving secretory cells after the
reduction in lung damage or the nature of the stimulus (e.g.,
DAMPS vs. pathogen-associated molecular patterns). Further
study of these mediators and their inducers in the lung in
response to inhalation injury and secondary bacterial infection
is warranted.
A significant clinical challenge in the field of trauma has
been how to suppress immune pathology without amplifying
patient susceptibility to infection. What we show here is that
attenuating early recruitment of neutrophils, when bacterial
infection has not yet emerged, protects the lung from injury
without preventing responses required to combat subsequent
infection. Future studies would benefit from implementing
larger animals such as sheep or pigs who can be placed on life
support and used to measure clinical parameters that are vital
to monitoring and improving patient outcomes. Because the
current study is limited to injuries from which mice can recover
without supplemental oxygen, future studies in larger animals
using life support strategies can determine whether mecha-
nisms and interventions outlined herein are applicable to more
severe injuries.
In summary, our studies present and describe a novel mouse
model of inhalation injury that more closely mimics inhalation
injury resulting from forest and/or house fires more effectively
than existing cotton smoke inhalation models. We have used
this experimental model to obtain well-defined temporal rela-
tionships between DAMPs, chemokines, cytokines, and innate
immune cell recruitment as well as susceptibility to opportu-
nistic infections observed in patients with inhalational injury.
We used this model to probe two key mechanisms associated
with the clinical observations, describing the complementary
and divergent roles of Nos2 and CXCL1. Together these and
previously published data illustrate the importance of using
relevant preclinical models to distinguish between inflamma-
tion, immunopathology, and protective immunity. This model
will improve the ability to differentiate between correlative and
causative relationships in inhalational injury. The studies pre-
sented here demonstrate that it is possible, using translationally
relevant models, to uncouple clinical phenotypes from out-
comes and therefore identify the most effective intervention
strategies.
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